Targeted Therapeutics - From Chemical Structures to Diagnostic and Therapeutic AgentsARMBRUSTER, Christine.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, issn 1381-6128, 126 p.Serial Issue

Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and TherapyLEITHA, Thomas.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 173-187, issn 1381-6128, 15 p.Article

Targeted Therapies in Lung CancerPIRKER, Robert; FILIPITS, Martin.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 188-206, issn 1381-6128, 19 p.Article

Chemoenzymatic Synthesis of Small Molecule Human TherapeuticsNINGQING RAN; EUGENE RUI; JINHUA LIU et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 134-152, issn 1381-6128, 19 p.Article

Targeted Drugs and Nanomedicine: Present and FutureDEBBAGE, Paul.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 153-172, issn 1381-6128, 20 p.Article

Targeted Therapies in Solid Tumours: Pinpointing the Tumour's Achilles HeelKORNEK, Gabriela; SELZER, Edgar.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 207-242, issn 1381-6128, 36 p.Article

Imatinib and Its Successors - How Modern Chemistry has Changed Drug DevelopmentMÜLLER, Bernhard A.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 120-133, issn 1381-6128, 14 p.Article